Aspirin Management for Lower Extremity Bypass and Arteriogram
For lower extremity bypass surgery, aspirin should NOT be discontinued and should be continued throughout the perioperative period. For diagnostic arteriogram, aspirin does not need to be stopped at all.
Lower Extremity Bypass Surgery
Aspirin continuation is the standard of care for vascular surgery, including lower extremity bypass procedures. The ACC/AHA 2007 guidelines explicitly state that "in noncardiac vascular surgery, preoperative aspirin is routinely used and is associated with improved peripheral bypass graft patency" 1. This represents a fundamental difference from other surgical procedures where aspirin discontinuation might be considered.
Key Evidence Supporting Continuation:
- Graft patency benefit: Continuing aspirin improves peripheral bypass graft patency, which is critical for the success of the revascularization procedure 1
- Cardiovascular protection: These patients have significant cardiovascular disease, and aspirin withdrawal poses thrombotic risks that outweigh bleeding concerns 1
- Bleeding risk is acceptable: While aspirin may increase the frequency of procedural bleeding (relative risk 1.5), it does not increase the severity of bleeding complications or perioperative mortality 1
The 2024 ACC/AHA Lower Extremity PAD guidelines reinforce that single antiplatelet therapy (typically aspirin) is standard after revascularization 2. The most recent evidence supports that aspirin's benefits in preventing graft thrombosis and cardiovascular events far exceed any increased bleeding risk in this specific population.
Diagnostic Arteriogram
Aspirin should be continued without interruption for diagnostic arteriogram. This is a low-bleeding-risk procedure, and the 2011 Canadian Cardiovascular Society guidelines specifically state that "patients who are receiving ASA and undergoing a diagnostic test associated with a low risk for bleeding may continue ASA without interruption" 3.
Important Caveats:
If the patient is on dual antiplatelet therapy (aspirin + clopidogrel):
- For bypass surgery: Continue aspirin, but clopidogrel should be held for 5 days before surgery if safely possible 1, 4
- The decision to hold clopidogrel depends on why it was started (e.g., recent coronary stent) and must balance stent thrombosis risk against surgical bleeding risk
- If surgery cannot be delayed and patient has a recent drug-eluting stent (within 12 months), both agents may need to be continued 5
Exception requiring aspirin discontinuation:
- Only if there are specific contraindications such as known severe bleeding disorder or recent major hemorrhage
- The French guidelines note that for procedures with exceptionally high bleeding risk (like neurosurgery), aspirin should be held for 5 days 4, but lower extremity bypass does not fall into this category
Rebound thrombosis risk: Evidence shows that aspirin withdrawal in patients with peripheral vascular disease can precipitate acute limb ischemia, with events occurring as soon as 7-60 days after discontinuation 6. This reinforces the importance of continuation in vascular surgery patients.